Please assess the completion status of the following clinical trial:

Trial Title: Contrast Enhanced Ultrasound and Shear Wave Elastography in Measuring Response in Patients With Breast Cancer Receiving Chemotherapy Before Surgery

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Women with histologically confirmed breast cancer (by core needle biopsy)~* Women with \>= 2 cm clinically or radiologically measureable breast cancer~* Women scheduled to receive neoadjuvant chemotherapy as part of their treatment plan~* Women competent to sign study specific written Informed Consent~* Women willing to comply with protocol requirements~Exclusion Criteria:~* Women who are pregnant~* Women who have undergone open surgical (excisional) biopsy for breast cancer diagnosis~* Women who have had a prior history of breast cancer in the same breast~* Women with known cardiac shunt, pulmonary hypertension or hypersensitivity to perflutren agent~* Women who cannot consent for themselves

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Diagnostic (CEUS, SWE) (Type: EXPERIMENTAL): Patients undergo dynamic contrast-enhanced ultrasound imaging and shear wave elastography at baseline, 2-3 weeks after initiation of chemotherapy, and before surgery.

Based on this trial design, predict the completion outcome and termination type (if applicable).